ADRB2 and breast cancer: Various downstream effectors contribute to β2-AR signaling-mediated angiogenesis, including activation of the mTOR pathway, downregulation of peroxisome proliferator-activated receptor γ (PPARγ), and upregulation of the Notch ligand Jagged-1 in BC cells 36.